Navigation Links
Enhanze in Medical News

Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Added to Nasdaq Biotech Index

...covering the family of human enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform designed to increase the absor...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10...

Baxter Reports Strong Third Quarter Sales and Earnings

...wn as KIOVIG(TM) in Europe). For patients using GAMMAGARD LIQUID 10% - currently administered intravenously - subcutaneous administration with enhanze Technology may increase convenience and improve the dispersion of the therapy. -- A collaboration with DEKA Research & Development Corp. and HHD...
Enhanze in Medical Technology

Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

- Co-Injection of rHuPH20 with Humira Estimated to Increase the Maximal Steady State Subcutaneous Bioavailability from 64% to 100% - SAN DIEGO, July 09, 2007 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing recombinant human enzymes...

Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme

...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...

Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...

Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously

... Phase I/II data showed that enhanze Technology(TM) enabled subcutaneous administrat... administered combination of GAMMAGARD LIQUID with enhanze Technology was 92 percent of the traditional, mont...ivotal Phase III trial using GAMMAGARD LIQUID with enhanze Technology pending discussions with regulatory aut...

Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Enhanze in Biological Technology

Halozyme Receives $5.5 Million Payment From Baxter

...s that affect the extracellular matrix. Halozyme's enhanze Technology is a novel drug delivery platform desi...e company has key partnerships with Roche to apply enhanze Technology to Roche's biological therapeutic compo... to 13 targets and with Baxter BioScience to apply enhanze Technology to Baxter's biological therapeutic comp...

Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients

...neous (SC) administration of GAMMAGARD LIQUID with enhanze Technology is an investigational study and when ap...gics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...

Halozyme Therapeutics Reports 2008 Third Quarter Financial Results

...n and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...

Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Present at Upcoming Investor Conferences

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Host Research Day for Investors and Analysts

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Present at Upcoming Investor Conferences

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
Other Tags
(Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer and retailer, has ... To bring more benefits to worldwide clients in this great ... for these brand new items. Clients can enjoy thwe special ... says gladly, “We are happy to announce such a promotion. ... new and old customers and strengthen our relationship with them. ...
(Date:7/11/2014)... 2014 Fadhits.com, the distinguished wedding dress ... of lace holiday dresses . To top it ... offered at discounted prices, up to 65% off. Clients ... this special offer. , Fadhits.com is devoted to ... dresses for the global clients. All its items come ...
(Date:7/11/2014)... prescribed exercise as medicine, according to a QUT ... is essential to reducing the risk of death ... QUT,s Institute of Health and Biomedical Innovation, said ... and mental health, health professionals should be prescribing ... Anderson and QUT,s Dr Charlotte Seib co-authored a ...
(Date:7/11/2014)... research from UC San Francisco shows that an ... Project helps women living with HIV disclose their ... and the safety and quality of their relationships., ... first author, Edward L. Machtinger, MD, director of ... percent of our patients are on effective antiretroviral ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
Breaking Medicine News(10 mins):Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:Exercise is the best medicine: QUT study 2Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
(Date:7/11/2014)... transplantation of mesenchymal stem cells can stimulate neurogenesis in ... Alzheimer,s disease (AD) and improve tissue and function injury ... reported on the therapeutic effect of adipose-derived stem cells ... effect on oxidative injury and neurogenesis in the brain ... School of Life Sciences, Tsinghua University, China transplanted ADSCs ...
(Date:7/11/2014)... hippocampus, the marginal division of the striatum is ... the impact degree of substance P in the ... Yan Yu and his team, College of Biophotonics, ... staining, that substance P receptor, neurokinin 1 was ... division of normal rats. Unilateral or bilateral injection ...
(Date:7/11/2014)... the normal circumstances, astrocytes participate in normal ... and exhibit therapeutic and repairing effects on ... have found that nerve cells differentiated from ... reduced viability, which produces influences on subsequent ... General Hospital, Hebei United University, China demonstrated ...
Breaking Biology News(10 mins):
Other Contents